Caution, this is an AI generated summary based on literature. This may have errors, see here for more.
Please share your feedback with us.
cfa-miR-103: Cfa-mir-103 is a microRNA that has been studied in the context of congestive heart failure and cardiac enlargement in dogs. It has been found to be significantly differentially expressed between dogs with congestive heart failure and those with mild to moderate cardiac enlargement [PMC4964495]. In dogs with mitral valve disease (MMVD) and mild to moderate cardiac enlargement or congestive heart failure, cfa-mir-103 is one of the upregulated miRNAs [PMC4964495]. It has also been identified as a suitable reference for normalization in miRNA expression studies [PMC10093184]. In the context of MMVD, cfa-mir-103 is upregulated in stage B1/B2 or C/D compared to stage A, while other miRNAs such as cfa-miR-582 and cfa-miR-487b are downregulated [PMC4490541] [PMC9607079]. Cfa-mir-103 has predicted targets such as TβRII and TβRIII, suggesting its potential role in canine MMVD [PMC4490541]. Overall, cfa-mir-103 shows differential expression patterns in different stages of MMVD and may play a role in the progression of the disease.
Genome locations
Gene Ontology annotations
Ancestor Chart
Loading ontology ancestors...
Failed to load QuickGO Ancestor chart
Sequence
Sequence features are shown above as colored rectangles.
Zoom in and click to view details, or
Reset